Skip to main content
SpringerLink
Log in

Iloprost and Thrombosis Prevention

  • Conference paper
Prostacyclin and Its Stable Analogue Iloprost

  • 77 Accesses

Abstract

It appears from this meeting that Iloprost, originally developed as an antiplatelet agent, mainly acts on mechanisms largely unrelated to platelet function. A so- called, still poorly characterized, cytoprotection seems to be the main mechanism by which Iloprost prevents thromboembolic complications in several diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Cerletti C, Latini R, Dejana E, Tognoni G, Garattini S, de Gaetano G (1985) Inhibition of human platelet thromboxane generation by aspirin in the absence of measurable drug levels in peripheral blood. Biochem Pharmacol 34: 1839–1841

    Article  PubMed  CAS  Google Scholar 

  2. de Gaetano G, Carriero MR, Cerletti C, Mussoni L (1986) Aspirin and vascular fibrinolysis: a new insight into the “aspirin dilemma”. Biochem Pharmacol (in press)

    Google Scholar 

  3. Dembinska-Kiec A, Kostka-Trabka E, Gryglewski RJ (1982) Effect of prostacyclin on fibrinolytic activity in patients with arteriosclerosis obliterans. Thromb Haemost 47: 190

    PubMed  CAS  Google Scholar 

  4. Gorman R, Bunting S, Miller OV (1977) Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins 13: 377–388

    Article  PubMed  CAS  Google Scholar 

  5. Levin RI, Harpel PC, Weil D, Chang TS, Rifkin DB (1984) Aspirin inhibits vascular plasminogen activator activity in vivo: studies utilizing a new assay to quantify plasminogen activator activity. J Clin Invest 74: 571–580

    Article  PubMed  CAS  Google Scholar 

  6. Marcus AJ (1979) Pathways of oxygen utilization by stimulated platelets and leukocytes. Semin Hematol 16: 188–195

    PubMed  CAS  Google Scholar 

  7. Pedersen AK, Fitzgerald GA (1984) Dose-related kinetics of aspirin: presystemic acetyla- tion of platelet cyclo-oxygenase. N Engl J Med 311: 1206–1211

    Article  PubMed  CAS  Google Scholar 

  8. Read NG, Radomski MW, Goodwin DA, Moncada S (1985) An ultrastructural study of stored human platelets after washing using prostacyclin. Br J Haematol 60: 305–314

    Article  PubMed  CAS  Google Scholar 

  9. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR (1983) Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67: 1016–1023

    Article  PubMed  CAS  Google Scholar 

  10. Szczeklik A, Gryglewski RJ, Nizankowski R, Skawinski S, Gluszko P, Korbut R (1980) Prostacyclin therapy in peripheral arterial disease. Thromb Haemost 19: 191–199

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Cardiovascular Clinical Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, Italy

    G. de Gaetano

Authors
  1. G. de Gaetano
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pharmacology, Copernicus Academy of Medicine, 16 Grzegórzecka, 31531, Cracow, Poland

    R. J. Gryglewski

  2. Cardiovascular Pharmacology, Schering AG, Müllerstraße 170–178, 1000, Berlin 65, Germany

    G. Stock

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag, Berlin Heidelberg

About this paper

Cite this paper

de Gaetano, G. (1987). Iloprost and Thrombosis Prevention. In: Gryglewski, R.J., Stock, G. (eds) Prostacyclin and Its Stable Analogue Iloprost. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71499-3_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71499-3_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71501-3

  • Online ISBN: 978-3-642-71499-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation